Mus Tales: a Hands-on View

Overview

Journal J Mammary Gland Biol Neoplasia

Date 2008 Jul 26

PMID 18654840

Citations 3

Authors

Lawrence J T Young

Affiliations

Soon will be listed here.

Abstract

The mouse model for breast cancer has developed into a most effective means of dissecting and understanding this devastating disease. The inbred transgenic mouse lends itself to biological, molecular, immunological, and genetic studies. The observation, dissection, transplantation, and subsequent amplification of precancerous mammary lesions and tumors give the scientist the means to readily study the tissues and design interventions and therapeutic drugs for the future eventual control of breast cancer. There are many inbred strains of mice, selected for specific characteristics. The mouse is easy to handle, breeds well, and does not require extensive facilities, funding, and handling such as monkeys, chimps, and other animal models. A huge advantage is the capability for the transplantation of tissues as well as gene manipulation, which make the transgenic mouse a major research resource. The mouse has served the scientific community well for over a century and will continue to do so in the quest for understanding breast cancer and other diseases.

Citing Articles

Histone Deacetylase Inhibitors and Microtubule Inhibitors Induce Apoptosis in Feline Luminal Mammary Carcinoma Cells.

Almeida F, Gameiro A, Correia J, Ferreira F Animals (Basel). 2021; 11(2).

PMID: 33671894 PMC: 7918990. DOI: 10.3390/ani11020502.

A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species.

Harman R, Curtis T, Argyle D, Coonrod S, Van de Walle G J Mammary Gland Biol Neoplasia. 2016; 21(1-2):51-66.

PMID: 27002722 DOI: 10.1007/s10911-016-9350-y.

Mammary stem cell research in veterinary science: an update.

Borena B, Bussche L, Burvenich C, Duchateau L, Van de Walle G Stem Cells Dev. 2013; 22(12):1743-51.

PMID: 23360296 PMC: 3668508. DOI: 10.1089/scd.2012.0677.

References

Cardiff R, Kenney N . Mouse mammary tumor biology: a short history. Adv Cancer Res. 2007; 98:53-116. DOI: 10.1016/S0065-230X(06)98003-8. View

Cardiff R, Anver M, Gusterson B, Hennighausen L, Jensen R, Merino M . The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene. 2000; 19(8):968-88. DOI: 10.1038/sj.onc.1203277. View

Lathrop A, Loeb L . Further investigations on the origin of tumors in mice. III. On the part played by internal secretion in the spontaneous development of tumors. J Cancer Res. 1916; 1(1):1-19. View

Nandi S . The histocompatability-2 locus and susceptibility to bittner virus borne by red blood cells in mice. Proc Natl Acad Sci U S A. 1967; 58(2):485-92. PMC: 335661. DOI: 10.1073/pnas.58.2.485. View

Namba R, Maglione J, Davis R, Baron C, Liu S, Carmack C . Heterogeneity of mammary lesions represent molecular differences. BMC Cancer. 2006; 6:275. PMC: 1762020. DOI: 10.1186/1471-2407-6-275. View

Cardiff R, WELLINGS S . The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia. 1999; 4(1):105-22. DOI: 10.1023/a:1018712905244. View

Medina D . The preneoplastic phenotype in murine mammary tumorigenesis. J Mammary Gland Biol Neoplasia. 2004; 5(4):393-407. DOI: 10.1023/a:1009529928422. View

BITTNER J . SOME POSSIBLE EFFECTS OF NURSING ON THE MAMMARY GLAND TUMOR INCIDENCE IN MICE. Science. 1936; 84(2172):162. DOI: 10.1126/science.84.2172.162. View

DeOME K, Miyamoto M, OSBORN R, Guzman R, Lum K . Effect of parity on recovery of inapparent nodule-transformed mammary gland cells in vivo. Cancer Res. 1978; 38(11 Pt 2):4050-3. View

10.

Morris D, Young L, Gardner M, Cardiff R . Transfer, by selective breeding, of the pathogenic Mtv-2 endogenous provirus from the GR strain to a wild mouse line free of endogenous and exogenous mouse mammary tumor virus. J Virol. 1986; 58(2):247-52. PMC: 252907. DOI: 10.1128/JVI.58.2.247-252.1986. View

11.

Namba R, Young L, Abbey C, Kim L, Damonte P, Borowsky A . Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ. Clin Cancer Res. 2006; 12(8):2613-21. DOI: 10.1158/1078-0432.CCR-05-2170. View

12.

Cardiff R . Protoneoplasia: the molecular biology of murine mammary hyperplasia. Adv Cancer Res. 1984; 42:167-90. DOI: 10.1016/s0065-230x(08)60458-3. View

13.

Namba R, Young L, Maglione J, McGoldrick E, Liu S, Wurz G . Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ. Breast Cancer Res. 2005; 7(6):R881-9. PMC: 1410776. DOI: 10.1186/bcr1317. View

14.

Cardiff R, Sinn E, Muller W, Leder P . Transgenic oncogene mice. Tumor phenotype predicts genotype. Am J Pathol. 1991; 139(3):495-501. PMC: 1886229. View

15.

Young L, Medina D, DeOME K, DANIEL C . The influence of host and tissue age on life span and growth rate of serially transplanted mouse mammary gland. Exp Gerontol. 1971; 6(1):49-56. DOI: 10.1016/0531-5565(71)90048-9. View

16.

Faulkin L, Mitchell D, Young L, Morris D, Malone R, Cardiff R . Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus. J Natl Cancer Inst. 1984; 73(4):971-82. View

17.

DANIEL C, DeOME K . GROWTH OF MOUSE MAMMARY GLANDS IN VIVO AFTER MONOLAYER CULTURE. Science. 1965; 149(3684):634-6. DOI: 10.1126/science.149.3684.634. View

18.

Sarkar N, Moore D . On the possibility of a human breast cancer virus. Nature. 1972; 236(5342):103-6. DOI: 10.1038/236103a0. View

19.

Cardiff R, Moghanaki D, Jensen R . Genetically engineered mouse models of mammary intraepithelial neoplasia. J Mammary Gland Biol Neoplasia. 2004; 5(4):421-37. DOI: 10.1023/a:1009534129331. View

20.

Levine P, Pogo B, Klouj A, Coronel S, Woodson K, Melana S . Increasing evidence for a human breast carcinoma virus with geographic differences. Cancer. 2004; 101(4):721-6. DOI: 10.1002/cncr.20436. View